ABL Biotechnologies Ltd. is setting up a 100 crore facility to manufacture DHA and EHA at the Marine Biotech Park at Visakhapatnam, Andhra Pradesh. It would be the World's 2nd & India's 1st DHA, EHA f
December 21, 2004 (Press Release) --
The Andhra Pradesh Government has developed a World Class Marine Biotech Park in Visakhapatnam, India, modeled on the lines of SP Biotech Park of Genome valley. One of its first occupents, Celgen Biologicals Pvt Ltd (Celgen), a wholly owned subsidiary of ABL Biotechnologies, is in the process of establishing India's first facility for the production of the essential fatty acid DHA at Visakhapatnam.
It has been one of the first companies to be allotted ten acres of land in the Marine Biotech Park at Visakhapatnam. According to the officials of Celgen, in spite of ABL Biotechnologies operations being based out of Chennai, it has looked at putting up the Celgen project in AP on the basis of development and support in that state. The technology for this project has been sourced from ABL Biotechnologies.
This project would be the first of its kind in India and second in the world for the production of Omega Fatty acids from plant sources. Celgen would be investing about Rs 100 crore in this area. It proposes to produce around 100 MT of DHA per annum.
The Andhra Pradesh Government has developed a World Class Marine Biotech Park in Visakhapatnam, India, modeled on the lines of SP Biotech Park of Genome valley. One of its first occupents, Celgen Biologicals Pvt Ltd (Celgen), a wholly owned subsidiary of ABL Biotechnologies, is in the process of establishing India's first facility for the production of the essential fatty acid DHA at Visakhapatnam.
It has been one of the first companies to be allotted ten acres of land in the Marine Biotech Park at Visakhapatnam. According to the officials of Celgen, in spite of ABL Biotechnologies operations being based out of Chennai, it has looked at putting up the Celgen project in AP on the basis of development and support in that state. The technology for this project has been sourced from ABL Biotechnologies.
This project would be the first of its kind in India and second in the world for the production of Omega Fatty acids from plant sources. Celgen would be investing about Rs 100 crore in this area. It proposes to produce around 100 MT of DHA per annum.
Email
Print
SPAM
